Introduction
Differentiation of granulocytes (granulopoiesis) takes place in the bone marrow over a period of 10 to 14 days. The first recognizable myeloid precursor is the myeloblast (MB), which differentiates to segmented neutrophils (SC) through the morphologically distinct stages of promyelocytes (PM), myelocytes (MC), metamyelocytes (MM), and band cells (BC). 1 Granulopoiesis is a complex process, in which a number of transcription factors play critical roles. 2, 3 This can be appreciated by recognizing that the differentiation stop associated with acute myeloid leukemia in most cases involves translocations or other mutations that disturb the function of a transcription factor. 4, 5 Further documentation comes from experiments involving ectopic expression of transcription factors in myeloid cell cultures 6, 7 and targeted disruption of genes encoding transcription factors in mice. [8] [9] [10] [11] Experimental evidence has shown that some transcription factors, such as C/EBP-and AML-1, 8, 9 are important during early granulopoiesis whereas others, such as C/EBP-and CDP, 10, 12 first exert their function in more mature neutrophil precursors. This demonstrates that timing of transcription factor expression and activation also is important for proper neutrophil differentiation.
To date, much of the information on the timed expression of transcription factors during neutrophil differentiation comes from investigation of in vitro differentiated CD34+ bone marrow cells or myeloid cell lines. 6, [13] [14] [15] [16] These studies, however, have some inherent shortcomings. First of all, it is difficult to reproduce the endogenous milieu and stimuli encountered by the neutrophil precursors in the bone marrow, which is a prerequisite for proper granulocytic differentiation. 6, 14 Second, data have often been obtained from asynchronously differentiating cell cultures, which may obscure the disappearance of an early expressed transcription factor due to a sustained presence of immature cells in the differentiated cell population. 6, 15, 17 Third, many of the widely used neutrophil cell lines, such as HL60 and NB4 cells, 18 lack the ability to express specific and gelatinase granule
For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From proteins. As the expression of these proteins are transcriptionally regulated 10, [19] [20] [21] this strongly suggests that the transcriptional program is corrupted in these cells.
The physiological role of transcription factors in granulopoiesis has also been analyzed by gene-targeting experiments. [8] [9] [10] [11] 22, 23 Although the hematopoietic cells in these cases encounter the proper microenvironment, the nature of these experiments usually allows only the earliest effect of a knocked-out transcription factor to be observed. Since some transcription factors are not only required for hematopoiesis in general (e.g. AML-1 and c-myb 9, 11 ) or commitment of a hematopoietic precursor (e.g. C/EBP-and PU.1 8, 22, 23 ) but also for the development of the precursor along the neutrophil lineage, the specific expression pattern of the factor during granulopoiesis may not be observed due to a lack of definitive hematopoiesis in these mice.
Furthermore, the phenotype of the mutation may not always be a direct consequence of the targeted disruption but instead a secondary effect caused by the lack of a gene product induced by the transactivator as exemplified by the reduced C/EBP-expression in C/EBP-knock out mice. 24 Finally, the resulting phenotype may depend on the design of the targeted disruption 25 as observed for the two PU.1 knock-out mouse models. 22, 23 To gain further insight into the in vivo expression of transcription factors during granulopoiesis, we have analyzed the mRNA and protein profiles of 14 transcription factors in neutrophil precursors from human bone marrow.
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Material and methods
Isolation of neutrophils and their precursors from bone marrow and peripheral blood. Bone marrow samples (15 mL) from healthy volunteers were used for isolation of neutrophil precursors by density centrifugation on a 2-layer Percoll (Amersham Biosciences) gradient, which resulted in the separation of bone marrow cells into three bands containing neutrophil precursors of different maturity: MB&PM, MC&MM, and BC&SC, respectively, as described previously. 19, 26 Contaminating erythrocytes in the BC&SC cell population were removed by 30 seconds of hypotonic lysis. Mature neutrophils from peripheral blood were isolated by centrifugation on Lymphoprep (Nygaard, Oslo, Norway) as described previously. 26, 27 Remaining erythrocytes were lysed by hypotonic lysis. controls were used CD16-PE, CD19-PE, CD33-PE, CD34-PE, CD56-PE, IgG 1 -PE, and IgG 1 -FITC (Becton Dickinson, San Jose, CA), CD49d-PE (BD PharMingen), CD5-PE, CD10-PE, CD61-FITC, and Glycophorin-A-PE (DAKO, Glostrup, Denmark), and CD14-PE and IgM-PE (Beckman Coulter, Miami, FL, USA). Cells were incubated with antibody for 15 min. at room temperature for labeling, washed twice in 0,5% BSA in PBS and fixed in 1% paraformaldehyde in PBS.
Removal of non-neutrophil hematopoietic cells by MACS
Flowcytometric analysis was performed using a FACScan (Becton Dickinson) for which settings and compensation were adjusted weekly using CaliBRITE TM Beads (Becton Dickinson). The data were analyzed using the CELLQuest and PAINT-A-GATE TM software (Becton Dickinson).
Staining of eosinophils.
Cells resuspended in 1% BSA in PBS, were cytocentrifuged onto a glass slide. Following methanol fixation, cells were stained 30 min. in 0.2% Fast Green (SigmaAldrich, St. Louis, MO, USA), rinsed in water, and counterstained in 1% Neutral Red (Sigma).
RNA isolation and Northern blotting.
Total RNA was isolated with Trizol (Invitrogen, San Diego, CA). The RNA was ethanol-precipitated and resuspended in 0.1 mM EDTA. For Northern blotting, 5 µg of RNA was run on a 1% agarose-gel and transferred to a Hybond-N membrane (Amersham Biosciences) as described. 19 Filters were pre-hybridized for 1-2 hours at 42°C in 6 mL ULTRAhyb (Ambion, Austin, TX, USA) and hybridized overnight at 42°C after addition of further 4 mL containing the 32 P-labeled probe and sheared salmon sperm DNA (10 µg/ml). The membranes were washed as described 19 and developed by a Fuji BAS2500 PhosphorImager. Membranes were stripped by boiling in 0.1% SDS before rehybridization. Probes used for hybridization were radiolabeled with [ -32 P] dCTP using the Random Primers DNA Labeling System (Invitrogen).
Sizes of the hybridizing bands were determined relative to 18S and 28S and found to be in accordance with previous reports (table 1) . For quantitative assessments, the intensities of the transcription factor signals were normalized to the hybridization intensity from a probe against 18S. 59 , respectively. The membranes were blocked in PBS with 0.5% Tween with the indicated amount of BSA and/or skimmed milk prior to addition of primary antibody. Protein sizes are as reported on the data sheets of the antibodies or, where indicated, in publications.
Results

Isolation of neutrophil precursor populations:
Previously, a method for purification of neutrophil precursors from human bone marrow by Percoll density centrifugation was developed in our laboratory in order to study the expression of neutrophil-specific granule proteins. 19, 26 By this method, the neutrophil precursors were separated into three cell populations enriched in MB&PMs, MC&MMs, and BC&SCs, respectively. 19, 26 For the investigation of neutrophil transcription factors it was, however, important that contamination with non-neutrophil cells was minimized since some transcription factors are shared between different hematopoietic lineages. 9, 11, 28 An immunomagnetic isolation step was therefore applied to the cells purifed on Percoll -density-gradients. Since no neutrophil-specific membrane marker exists, which is expressed at all stages of granulopoiesis, we decided to use a depletion protocol with antibodies directed against plasma membrane proteins present on the erythroid (glycophorin-A), B-lymphoid (CD19), T-lymphoid (CD2 and CD3), monocytic (CD14), megakaryocytic (CD61), and natural killer cell (NK) (CD56) lineages. The membrane marker CD49d is expressed on mature eosinophils and on neutrophil precursors up to the metamyelocyte stage. 29 Antibodies against CD49d were therefore included when purifying the BC&SCs population in order to remove contaminating eosinophils. Neutrophil granulocytes from peripheral blood (PMNs) were also included in the study as they represent the most mature form of this cell. The PMNs were isolated by Lymphoprep-density centrifugation and further purified by removal of contaminating eosinophils on a MACS column using anti-CD49d antibodies.
By inclusion of the immunobead purification step, the mean percentage of contaminating cells was reduced from 68%, 22%, 16%, and 4.0% to 7.7%, 2.0%, 2.2%, and 0.7% for the A differential count of the three neutrophil precursor cell populations showed a distribution profile similar to that reported previously 19, 26 only demonstrating a slightly higher percentage of band cells in the MC&MM fraction in this study (table 4) . To further ensure that the distribution profile of the neutrophil precursors was not biased by the MACS purification step, cells from the three bone marrow populations and PMNs were analyzed for the presence of granule protein mRNAs known to be found specifically in MB&PMs (myeloperoxidase), MC&MMs (lactoferrin),
and BC&SCs and PMNs (the fMLP-receptor), respectively. 19, 26, 30 As shown in figure 3A+B , the distribution profile of the granule markers was as expected and in accordance with previously published distribution profiles. transcripts is usually performed. Previously, we found that the level of GAPDH mRNA decreases with neutrophil maturation and therefore examined -actin and 18S RNA levels to determine whether they were a better choice. Relative hybridization intensities of 12 (18S) and 17 ( -actin)
Northern filters, each containing 5 µg total RNA from the four neutrophil cell populations, are figure 3C . Levels of -actin mRNA were approximately 45% lower in MB&PM and PMNs than in the two other cell populations whereas 18S appeared to be more evenly expressed demonstrating, at most, 25% difference between any two cell populations. For this reason we choose 18S for normalization of our transcripts. All data presented are the combined result of three hybridizations, each normalized to 18S. The distribution of transcription factors was also examined by Western blotting. In this case equal loading was assured by probing with an antibody againsttubulin.
When analyzing transcript levels one should bear in mind that only the relative hybridization MPO and elastase. [31] [32] [33] GATA-1 is important for erythroid and eosinophil development but can also be found in early myeloid precursors. 34, 35 CDP is a transcriptional repressor that blocks expression of the genes encoding specific granule proteins and gp91 phox in MBs and PMs. 12 A similar distribution profile was found for the AML1b (~ 7 kb) and AML1c (~ 6.5 kb)
transcripts, which arise from the AML1 gene by use of two different promoters, 36 with highest mRNA levels in MB&PMs and lower levels in more mature cells ( fig. 4A+B ). Also for c-myb, transcripts of two different sizes were observed ( fig. 4A ). The 3.8 kb mRNA encodes a transcriptional activator and the 2.5 kb mRNA an inhibitor. 37, 38 Both splice products were abundant
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From in the two most immature cell populations and almost undetectable from the band cell stage an onwards. The amount of the largest c-myb transcript (3.8 kb) was three to four-fold larger in the MB&PMs relative to the MC&MM whereas the opposite was the case for the 2.5 kb c-myb transcript, which increased three-fold in the MC&MMs compared to the MB&PM population. In contrast to the transcript profiles described above, a strong hybridization signal was measured for CDP mRNA in all four cellpopulations and demonstrated no significant change in the transcript level with maturity ( fig. 4A+B) 
Transcript profiles for the family of C/EBP transcription factors:
Members of the C/EBP transcription factor family are required for proper neutrophil differentiation. Since homo-and heterodimerization of different C/EBP family members as well as functional substitution of one C/EBP dimer by another can occur, 41 we decided to examine the transcript profile of the entire C/EBP-family (i.e. C/EBP-, -, -, -, -, and -). 41 Due to high homology in the coding region, C/EBP probes were designed towards the 3`-region of the mRNA. The specificity of the probes was 
Transcript profiles for PU.1, Elf-1, c-jun, and c-fos.
The ets factors PU.1 and Elf-1 are both found in neutrophils and a requirement for PU.1 in early granulopoiesis has been demonstrated. 20, 22, 23 We therefore chose to examine the expression profile of these two transcription factors. As c-jun acts as a co-activator of PU.1 in monocytic differentiation 46 we decided to include also this factor, as well as c-fos, a well documented dimerization partner of c-jun. 47 For 37 was observed indicating that the 2.5 kb mRNA either also encodes the 75 kDa activator or that the amount of the inhibitory form is below the detection limit of our antibody ( fig. 4C ).
Although some mRNA for c-myb is found in MC&MM we were only able to detect a strong c-myb
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signal by Western blotting in MB&PMs. We were unable to detect CASP with our CDP antibody as the antibody was directed against a part of CDP that is not contained in CASP.
Both the 42 and 30 kDa isoforms of C/EBP-were detected ( fig. 5C ) representing the transactivation-competent full-length and the N-truncated transdominant repressor forms of the protein, respectively. 48 The larg er isoform was most prominent in all cell populations indicating that transactivating competence of C/EBP-was maintained thoughout granulopoiesis. Two forms of C/EBP-has been reported in liver cells (a 43 kDa activator and a 20 kDa form that attenuate transcriptional activation of the 43 kDa isoform). 49 Our antibody should detect both proteins but only the 43 kDa type was seen, indicating that only the transactiving type of C/EBP-is present in the neutrophil precursors. Three isoforms of C/EBP-of 32, 27, and 14 kDa were seen in the neutrophil precursors. As for the mRNA, the vast majority of C/EBP-protein was found in MC&MMs ( fig. 5C ). The 32 kDa transactivation-competent form was the most prominent of the three C/EBP-isoforms and the 27 and 14 kDa forms, which lack transactivating potential, constituted only a very minor portion of the C/EBP-proteins. 44, 50 . The 14 kDa form was only seen following prolonged exposure. The same expression pattern of C/EBP-was found with another C/EBP-antibody (table 2) .
Discussion
It is well established that a finely tuned timing of transcription factor expression is pivotal for correct neutrophil differentiation. Expression of the receptors for G-CSF and IL6, 51 the azurophiland specific granule proteins, 10, 20, [31] [32] [33] and transcriptional regulators such as PU.1, C/EBP-, and C/EBP-7,24,52 is governed by the emergence and/or disappearance of key transcription factor(s).
Current knowledge about the expression pattern of transcription factors during granulopoiesis has primarily been obtained from work with neutrophil cell lines, bone marrow derived CD34+ cells, and murine knock-out models. Although much information can be gained from such experiments, the data may not always be a true representation of the in vivo situation due to the previously mentioned limitations of these model systems. For this reason we decided to examine the in vivo profile of transcription factors during granulopoiesis in four distinct cell populations of different maturity from human bone marrow and peripheral blood.
It is possible to obtain a finely tuned transcription factor profile in relation to neutrophil maturation based on the mRNA and protein levels in the four neutrophil cell populations if the following assumptions are fulfilled. The first assumption is that the relative level of 18S mRNA is constant in the cells such that it can be used to normalize the levels of mRNA for the transcription factors ( fig. 3C ). Second, if the level of a specific mRNA is low in one cell population and increases in the next cell population, which contains more mature cells, then it is assumed that the low mRNA level in the more immature cells is not due to a uniform low level in all the cells, but instead to a high level in the most mature cells of this cell population resulting in a gradual increase in the mRNA level. The alternative interpretation would be that uniform transcript levels exist in all cells of the population, despite the fact that these cover a span of maturation artificially sampled into the same population by the limitations set by the density of the separating Percoll medium, 53 and that steep changes in the mRNA level occur at the transition between the different cell populations.
Third, although the presence of a particular transcript does not necessarily imply the synthesis of the For personal use only. on October 3, 2017. by guest www.bloodjournal.org From concurrent protein and conversely, the disappearance of a given mRNA does not always mean that the protein it encodes also disappears, co-expression of an mRNA and its cognate protein is usually observed for cytosolic proteins. 54 Our protein expression data demonstrate that this indeed is the case for the transcription factors investigated here. This is in contrast to granular proteins such as MPO and lactoferrin, which are stored in granules (and thus protected from degradation) until exocytosed. 30 In this case, the protein can be detected long after the transcript has disappeared. 19, 26 If the assumption is made that gradual changes of mRNA and protein levels occur, then the hypothetical distribution profile depicted in figure 7 can be made. Although alternative splicing and translation, as well as posttranslational modifications such as phosphorylation, acetylation, and proteolytic processing may also influence the activity of a transcriptional regulator, and thus have to be taken into consideration, we believe that the in vivo expression pattern of the 14 transcription factors presented here to a large extent can explain the temporal regulation of stage-specifically expressed genes during granulopoiesis. In accordance with previous reports, 31, 55 AML-1 and c-myb were found to be strongly expressed at the early stages of neutrophil differentiation, which fits with the requirement of both
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From these transcription factors for the expression of azurophil granule proteins such as MPO and elastase. [31] [32] [33] Down-regulation of c-myb after the myelocyte stage was anticipated since c-myb blocks differentiation and induces proliferation and therefore was expected to disappear at the stage of differentiation where cell cycle arrest and initiation of terminal neutrophil differentiation takes place. 1 The same consideration is likely to apply for AML-1, as it also stimulates proliferation (in part by repressing transcription of the cell cycle inhibitor p21 Cip1 ). 56 The level of CDP remained almost unaltered during neutrophil differentiation, which was surprising since CDP activity was expected to disappear at the myelocyte stage where expression of specific granule proteins is initiated. The repressive effect of CDP in granulopoiesis has been demonstrated in HL60 cells and murine 32Dcl3 cells where transcription of the genes encoding gp91phox 57 and specific granule proteins was inhibited by a continued expression of CDP -both by direct inhibition of the genes 12, 58 and indirectly by inhibiting the synthesis of C/EBP-, 52 which is essential for specific granule protein gene expression. 10, 21 Recently it has been shown that CDP protein is synthesized in HL60 cells during the entire process of granulocytic differentiation.
However, the binding capability of CDP disappears in the more mature cells due to phosphorylation of the protein. 59 A similar inactivation of CDP may occur in myelocytes in vivo. This suggests that the observed repression of specific granule gene activity in cell cultures that overexpress CDP is due to an overload of the phosphorylating capacity of these cells rather than a consequence of a continued CDP synthesis. No function has been ascribed to CASP but it has been speculated that it may regulate CDP-activity since CDP and CASP are able to heterodimerize. 39, 60 C/EBP-is required for granulopoiesis as demonstrated by the selective block in neutrophil differentiation in mice with a targeted disruption of the C/EBP-gene 8 and the induction of terminal granulocytic differentiation in 32Dcl3 cells in response to induced expression of C/EBP-. 7 C/EBP-is also needed for gene expression of both the early neutrophil markers MPO and elastase 33, 61 and of the receptors for IL-6 and G-CSF, which are expressed also at later stages of neutrophil development. 7, 51 In agreement with the above requirements, C/EBP-is found throughout neutrophil differentiation. A similar expression pattern for C/EBP-has been observed for HL60 cells and NB4 cells induced to granulocytic differentiation by retinoic acid. 43 This is in contrast to the transcript levels found during differentiation of adipocytes and hepatocytes where a steep increase in the C/EBP-mRNA level is observed when proliferation ceases and terminal differentiation is initiated. 62 The proposed antiproliferative effect of C/EBP-seen in the latter cell types 63 is therefore not likely to be relevant in neutrophils.
The levels of both C/EBP-, C/EBP-, and C/EBP-increased dramatically at the stage where proliferation ceases in neutrophils (i.e. metamyelocytes 1 ). Since these proteins in other cell systems are associated with termination of proliferation 64,65 a role for these C/EBPs (rather than C/EBP-) in neutrophil cell cycle arrest can therefore be envisaged. It is, however, also possible that C/EBP-, C/EBP-, and/or C/EBP-are required for transcriptional initiation of late neutrophil markers such as gelatinase, fMLP-receptor, CD35, and TLR4. 19, 26, 66 C/EBP-lacks a transactivating domain and can inhibit the transactivating potential of other C/EBPs. 41, 67 A high expression of C/EBP-has been associated with proliferation although the mechanism by which it governs this is unknown. 67, 68 The strong expression of C/EBP-only in the highly proliferative immature neutrophil precursors supports such a function also in granulopoiesis.
Previous publications have demonstrated peak levels of C/EBP-mRNA in promyelocyte and late myeloblast-like cell lines and a sustained expression in PMNs from peripheral blood. 15, 44 This is in contrast to the findings in this report where the peak C/EBP-level is found in MC&MMs. Our data, however, fit the phenotype of C/EBP-knock out mice 10 and specific granule deficiency patients 21 where the earliest steps of neutrophil differentiation are unaffected whereas expression of specific granules at the myelocytic stage is completely abolished due to the lack of C/EBP-. The peak expression of C/EBP-in MC&MMs and its disappearance in more mature
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From cells could thus explain the confined expression of the specific granule genes in myelocytes and metamyelocytes. 19 The disparity between the C/EBP-mRNA profiles in bone marrow derived neutrophil precursors and in cell cultures may be due to a mal-induction of C/EBP-transcription by retinoic acid 14 or G-CSF 6 in the latter case as both these substances are commonly added to the growth media in order to induce neutrophil differentiation of cell cultures. Our data furthermore indicate that the previously reported presence of C/EBP-transcript in peripheral blood neutrophils is caused by contaminating eosinophils since a complete lack of measurable C/EBP-signal by
Northern blot analysis was demonstrated following removal of the eosinophils from this cell population ( fig. 2B+C ). We only detected a C/EBP-mRNA of ~1.4 kb by Northern blotting and
were not able to identify the earlier reported C/EBP-splice variant at 2.4 kb even following prolonged exposure of the Northern blot. 44 As our probe was designed to recognize the 3`-end of the C/EBP-mRNA, which is included in all splice variants, our data indicate that the 2.4 kb splice product is either not made in vivo or that the amount produced is so low that a more sensitive detection method such as RT-PCR is required for its identification.
Targeted disruption of PU.1 abolishes or severely impairs the production of neutrophils.
22,23
The few neutrophils formed in the PU.1 knock-out mice are able to differentiate morphologically to PMNs but fail to express specific granule genes and gp91 phox . 20 Although mRNAs for azurophil granule proteins were detected in the PU.1 null mice, demonstrating that PU.1 was not essential for their transcription, other experiments have shown that PU.1 is required for optimal gene expression of early neutrophil markers such as MPO, proteinase-3, and elastase 33, 61, 69, 70 as well as of very late markers such as TLR4. 66, 71 Together, these data fit the transcript pattern observed here where PU.1 is found at all stages of neutrophil differentiation. The expression profile of the second ets factor included in this study, Elf-1, was quite different from that of PU.1 demonstrating that ets factors are also expressed in an individual manner. Elf-1 is unable to functionally substitute for PU.1 72 and has been found to cooperate with PU.1 in the expression of the NADPH-oxidase component gp91 phox indicating an individual regulatory specificity of this transcription factor. 73 Transcriptional competence of PU.1 during monocytic differentiation is dependent upon cjun as a non-DNA-binding co-activator. 74 The same may apply to neutrophil differentiation and the expression pattern demonstrated here indicates that c-jun would be available for such a function during late granulopoiesis. Expression of c-fos, which often is found heterodimerized with c-jun in the transcriptional transactivator complex AP-1, 47 is also primarily found at the late stages of development and in PMNs from peripheral blood. It is possible that c-fos, through heterodimerization with c-jun, can modulate the transcriptional capacity of c-jun -either by reducing the transactivating potential of PU.1 and/or by forming a transcriptional active AP-1 complex. 74 Since the "active concentration of PU.1" in the cell is critical for its transactivating increases further due to a positive feed-back mechanism. 75 In myelocytes, the decrease in AML-1 and c-myb levels halt expression of azurophil granule genes. Furthermore, reduction of the active CDP level causes its repression of the genes for C/EBP-, gp91 phox , and the specific granule proteins to be relieved. C/EBP-then induces transcription of the specific granule genes and of C/EBP-. 24 In band cells, downregulation of C/EBP-causes the cessation of specific granule gene transcription. Cell cycle arrest and initiation of terminal neutrophil differentiation in metamyelocytes may be a result of the combined disappearance of the pro-proliferative
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From transcription factors c-myb, AML -1, C/EBP-, and CDP (which inhibits p21 cip1 ) 76 and emergence of potential anti-proliferative factors such as C/EBP-and -. At present, it is unknown which transcription factors regulate the timed onset of very late neutrophil markers such as the fMLPreceptor, TLR2, TLR4, and CD35 which are all preferentially expressed in band cells, segmented cells, and PMNs. The data presented in this work indicate that C/EBP-, C/EBP-, and C/EBPmay play a role. In conclusion, the transcription factor profiles described here may to a large extent explain the timed gene expression of granule protein genes and cell cycle arrest during granulocytic differentiation.
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